The novel treatment of this peptide represents a exciting advance in the handling of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets multiple pathways – the GLP-1 hormone and GIP – leading to enhanced glucose management and anticipated weight loss. Experts are exploring its future effects and role in the broader treat